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ABSTRACT
In medical sciences, a biomarker is “a characteristic that is objectively measured and
evaluated  as  an  indicator  of  normal  biological  processes,  pathogenic  processes,  or
pharmacologic  responses  to  a  therapeutic  intervention”.  Molecular  experiments  are
providing rapid and systematic approaches to search for biomarkers, but because single-
molecule  biomarkers  have  shown  a  disappointing  lack  of  robustness  for  clinical
diagnosis,  researchers  have begun searching for distinctive  sets  of molecules,  called
“biosignatures”.  However,  the  most  popular  statistics  are  not  appropriate  for  their
identification,  and  the  number  of  possible  biosignatures  to  be  tested  is  frequently
intractable.  In  the  present  work,  we  developed  a  “multivariate  filter”  using  genetic
algorithms  (GA)  as  a  feature  (gene)  selector  to  optimize  a  measure  of  intra-group
cohesion and inter-group dispersion. This method was implemented using Python and R
(pyBioSig,  available  at  https://github.com/fredgca/pybiosig  under  LGPL) and can be
manipulated via graphical interface or Python scripts. Using it, we were able to identify
putative biosignatures composed by just a few genes and capable of recovering multiple
groups simultaneously in a hierarchical clustering, even ones that were not recovered
using  the  whole  transcriptome,  within  a  feasible  length  of  time  using  a  personal
computer. Our results allowed us to conclude that using GA to optimize our new intra-
group  cohesion  and  inter-group  dispersion  measure  is  a  clear,  effective,  and
computationally  feasible  strategy  for  the  identification  of  putative  “omical”
biosignatures that could support discrimination among multiple groups simultaneously.
INTRODUCTION
Complex systems are present in any human issue, but their intrinsic structure
prevents them from being intuitive, and specific methods are required for interpreting
them.  For  the  scientific  community,  one  of  the  valid  strategies  is  to  reduce  their
complexity. This method, frequently known as feature or dimensionality reduction, tries
to  find  single  features  or  small  sets  of  features  that  reflect  the  whole  scenario,  or
summarize all features in a smaller number of compounded new ones (Saeys et al, 2007;
Hilario and Kalousis, 2008; Li et al, 2008; Ringnér, 2008;).
In  biological  systems,  these  distinctive  features  are  generally  named
“biomarkers” and can be found and made useful in any area of the natural sciences, but
medical research is seeking them most intensely (Gustaw-Rothenberg et al, 2010; Parida
and Kaufmann, 2010; Pedraza et al, 2010). In the medical context, a biomarker is “a
characteristic  that  is  objectively  measured  and  evaluated  as  an  indicator  of  normal
biological processes, pathogenic processes, or pharmacologic responses to a therapeutic
intervention” (Group., 2001). Although many characteristics have the potential  to be
used  as  biomarkers,  molecular  experiments  are  providing  rapid  and  systematic
approaches to search for them (Liu et al, 2005; Agranoff et al, 2006; Kussmann et al,
2006; Gonzalez-Juarrero et al, 2009; Nagaraj, 2009). 
Medical  biomarkers  could  help  researchers  to  understand  biochemical
(Fernandes et al, 2004) or immune responses (Querec et al, 2009), classify cancer in
types  or  levels  (Brawer,  2000;  Liu  et  al,  2005;  Pedraza  et  al,  2010),  identify  the
progression and stages of any other disease (Saeys et al, 2007; Gonzalez-Juarrero et al,
2009;  Gustaw-Rothenberg  et  al,  2010),  evaluate  effectiveness  of  and  patient
responsiveness  to  a  treatment  (Parida  and  Kaufmann,  2010),  and  predict  behaviors
(Fernandes et al, 2004), among other applications.
As  single-molecule  biomarkers  for  clinical  diagnosis  have  shown  a
disappointing  lack  of  robustness  (Brawer,  2000),  researchers  have  been looking  for
distinctive sets of molecules,  called “biosignatures” (Liu et al,  2005; Agranoff et  al,
2006; Gonzalez-Juarrero et al, 2009; Pedraza et al, 2010). Simple calculations of fold
changes, t and F tests, do not measure classification accuracy and do not explore gene
combinations (Xiong et  al,  2001). Otherwise,  distance between samples can be used
with multivariate data and is appropriate for classifications. A brief discussion of it can
be found in the paper by D'haeseleer (D'haeseleer, 2005).
Distances  can help with handling many variables  at  once but do not help us
select  them.  On the  other  hand,  trying  all  possible  gene  combinations  is  frequently
impossible (Hilario and Kalousis, 2008). Genetic algorithms (GA) is a heuristic search
technique that performs optimizations by mimicking the process of natural evolution
(Goldberg, 1989) and can be used as a feature (gene) selector. The paper by Ooi and Tan
(2003) provided a short description of the method and how it can be modeled for gene
selection.
In  the  present  work,  we  developed  and  implemented  a  “multivariate  filter”
(Saeys et al, 2007) that optimizes the discrimination of any number of groups, using
genetic algorithms as the feature (gene) selector and a simple measure of intra-group
cohesion and inter-group dispersion as objective function. We believe that the method
presented and its  implementation would be useful for researchers'  efforts  to identify
putative biosignatures. 
METHODS
Software framework
We developed  the  pyBioSig  program  using  Python   (Python  Programming
Language) as the main programming language and the R package (The R Project for
Statistical  Computing)  as the statistical  framework. The pyEvolve library (Christian,
2009) was used as Genetic Algorithms framework, pyGTK (PyGTK: GTK+ for Python)
for interface development, and the RPy library  (RPy: A simple and efficient access to R
from Python)  for  Python/R communication.  We employed the  pvclust  library  for  R
(Suzuki  and  Shimodaira,  2006)  to  perform  hierarchical  clustering  and  to  calculate
bootstrap and approximately unbiased p-values (Suzuki and Shimodaira, 2006) of each
generated cluster.
Genetic algorithm parameters
We used genetic algorithm as a gene (feature) selector. The parameters used in
all analyses were adapted from (Peng et al, 2003), with RouletteWheel as the selector, a
mutation ratio of 1%, a crossover ratio of 80%, a population with 40 individuals, and
50000 generations.
The objective function to be optimized by our GA was the minimization of n
largest and mean distances among members from the same group and the simultaneous
maximization  of  the  n  smallest  and mean distances  among members  from different
groups, as summarized by the formula 
  
1000−(wmax+F .wmeanbmin+F .bmean )−size penalty
where wmax and wmean represent the sum of the n largest and the mean distances
among members from the same group, respectively, and bmin and bmean represent the
sum of the n smallest and the mean distances among members from different groups,
respectively. “F”, a weight for the mean distances on the equation, and “n” were set by
default to 0.2 and 1, respectively. Euclidean distance was used as the default distance
measure in all analyses.
To obtain biosignatures with a reduced number of probes, we also included a
linear penalty function that decreases with the number of genes included. This penalty is
canceled  when the biosignature  reaches  a desired range and is  set  to  the maximum
penalty when the biosignature size becomes smaller than the minimum size.
Benchmarking
The ability of our method to selectively recover informative probes was tested
over  artificial  datasets,  composed  of  different  numbers  of  known  informative,
uninformative and noisy probes. Informative probes were generated following a normal
(s.d.: 0.3) or uniform  (boundaries: ±0.6 from the midpoint) distribution with different
means or midpoints, respectively, for each or one group. Uninformative probes were
generated  following  a  normal  distribution  (s.d.:  0.75)  with  the  same  mean  for  all
samples. Values from noisy probes were generated following a normal distribution (s.d.:
0.25) with different  means for at  least  one group with members assigned randomly.
Means or midpoints ranged from 3 to 15 in the integer set and were randomly assigned.
The gain  in  power  of  classification  was evaluated  by  multidimensional  scaling  and
hierarchical clustering, comparing the results of our specific filter against the results of
Anova (a nonspecific filter).  Bootstrap and approximately unbiased p-values (Suzuki
and Shimodaira, 2006) were used to evaluate the robustness of the clusters produced
and of the probe set selected. 
The  same  evaluations  were  also  performed  with  the  following  published
microarray  data:   GSE4511 (Maurer  et  al,  2005),  GSE5500  (Bisping  et  al,  2006),
GSE5429 (Fernandes et al, 2004). With the GSE5429 dataset, in order to evaluate the
tendency of our method to overfit, we also performed a round o cross-validation in the
form of  leave-one-out,  testing  the  classification  of  all  odd  samples  using  a  K-NN
classifier, using two neighbors for classification (Larrañaga et al, 2006).
Preprocessing and nonspecific filtering of published microarray data
Bioconductor (Gentleman et al, 2004) was used to perform all preprocessing and
nonspecific filtering tasks. Microarray data were loaded using the Affy package (Gautier
et  al,  2004).  Background  adjustment,  quantile  normalization  and  median  polish
summarization were performed in all microarray data using GCRMA (Wu et al, 2004).
Those probes with log2 signal  lower than  2.5 in  more than 75% of the samples  or
interquartile range lower than 0.5 were eliminated using the Genefilter package. Probes
with p-value greater than 0.01 (without any correction for multiple testing) in an Anova
analysis were also removed. 
RESULTS
Our method was implemented using Python and R in a software that we called
pyBioSig, available at https://github.com/fredgca/pybiosig under LGPL. The parameters
of a single analysis using pyBioSig can be set via our graphical interface, but batch
analyses can be also performed using Python scripts in order to optimize the value of
these different parameters, like biosignature size and objective function weights. 
To evaluate  and  test  the  pyBioSig  method,  we  created  some  data  sets  with
40,000 artificial probes and four groups of 15 samples each. From these 40,000 probes,
4  (0.01%)  had  coherent  information  for  all  four  groups,  4  (0.01%)  had  coherent
information for just one group and no information for the others, 4,000 (10%) had noisy
information that clusters samples in groups different from those we have originally set,
and 35,992 (89.9%) probes had no information, i.e., all samples had values coming from
the  same distribution.  In  one  of  these  data  sets,  for  example,  the  nonspecific  filter
(Anova) selected 388 probes, including all  8 informative,  344 uninformative and 36
noisy probes. 
The pyBioSig  parameters  were  set  as  described  in  Material  and Methods  to
search for the most distinctive probe set with a size ranging from 6 to 12 probes. In 30
independent searches over three artificial data sets, like that mentioned above, created
independently,  our  method  selected  informative  probes  predominantly  (figure  1).  In
numbers,  96.6%  of  the  putative  biosignatures  contained  none  or  just  a  single
uninformative/noisy probe. These searches, using a single personal computer with an i3
Intel processor, took a median of 6.7 hours with an interquartile range of 0.22 hours (13
minutes), but reasonable results could be obtained in less than 90 minutes.
As we can see in figure 2, a representative solution from our artificial data, the
probe set from pyBioSig showed visible improvement over the nonspecifically filtered
set. By hierarchical clustering, the main evidence of this improvement was the correct
clustering of all samples, which did not happen with the nonspecifically filtered data.
Higher bootstrap and approximate approximately unbiased p-values [31] for the known
groups  indicated  more  stable  clusters.  We were  also  able  to  observe  that  distances
among  members  from  the  same  group  were  smaller  and  more  uniform,  whereas
distances among members from different groups were larger in the pyBioSig result than
in the nonspecifically filtered. With a multidimensional scaling plot, we could observe
that the groups in our probe set were more compact, but different groups were more
dispersed from each other, as expected.  
Once we had obtained evidence that our methodology and its implementation
were effective in retrieving probes with information for discrimination among groups
selectively, we tested pyBioSig with real microarray data. With the data sets GSE4511
(Maurer et al, 2005), GSE5500 (Bisping et al, 2006), GSE5429 (Fernandes et al, 2004)
and unpublished data from our laboratory (Rodrigues RF, et al. unpublished results), we
were able to obtain results as successful as with our artificial data set. Figure 3 shows an
example of the improvements with the data set GSE5429, which has eight groups with
four samples each, representing mRNA extracted from the hippocampus of eight mouse
strains with different aggressive behavior. With hierarchical clustering, all groups were
correctly clustered with higher bootstrap and approximately unbiased p-values. In the
multidimensional scaling plot, we also observed more compact groups but more distant
from  each  other.  The  results  of  our  cross-validation,  described  in  Material  and
Methodos, classified all testing samples correctly, showing no tendency to overfit the
biosignatures to the training data.
DISCUSSION
The biomarker  quest  seeks  simple  signals,  mainly  at  the  molecular  level,  to
understand or answer questions like “Which type of cancer does patient X have?”, “Will
BCG  protect  this  child/population  against  tuberculosis?”,  “In  which  stage  is  the
disorder?”.  The ideal  would be finding one cheap,  easy, and objective measure that
would robustly answer the question or predict the outcome. However, taken together
that single-feature markers have disappointing lack of robustness (Brawer, 2000) and
most questions are multi-class problems, i.e., they are not yes/no questions, we need a
set of markers or a signature to have confident results.
Considering that we can include or not include a molecule in a signature, having
x candidate  molecules,  we have 2x possible  biosignatures.  Frequently, a  nonspecific
filtering of “omical” data leaves us with something around 200 candidate molecules,
which means 2200 possible signatures. Considering that our universe has a history of less
than 260 seconds, it is clear that we cannot try all possible combinations and that we
need an intelligent approach.
In the present work, we developed a method based on genetic algorithms that
seeks probe sets of predetermined size that improve group discrimination. The method
was implemented as a computer program that we called pyBioSig. As shown in our
results, starting with an artificial data set with 388 probes, the result of a nonspecific
filtering employing Anova, we were able to find probe sets predominantly containing
only informative probes. This result indicates that our method is effective in identifying
and selecting informative probes within a feasible length of time with an inexpensive
personal computer. 
Applying  the  same  strategy  to  real  microarray  data,  we  had  similar  results,
making groups internally more cohesive but externally more dispersed. We highlight the
results obtained with the GSE5429 data set. This data set has eight groups, representing
mRNA extracted from the hippocampus of eight mouse strains with different aggressive
behavior. By applying a nonspecific filter, 646 probes were selected, but hierarchical
clustering using Euclidean distance and average linkage were not able to cluster samples
according to their strains. Likewise, multidimensional scaling revealed very confused
groups. However, when we applied the pyBiosig method, we were left with 11 probes
that robustly clustered all samples according to their strains. Of 50 randomly created
probe sets of the same size from the nonspecifically filtered data, none of them clustered
all  samples  correctly.  Altogether,  these  results  indicate  that  our  method  and  its
implementation are effective in making groups more distinguishable.
The  method  with  the  current  objective  function,  described  in  the  Methods
section,  tries  to  minimize  the  sum of  the  n  largest  and  the  mean  distances  among
members from the same group while maximizing the sum of the n smallest  and the
mean  distances  among  members  from  different  groups.  The  rationale  behind  this
objective function was to be a mid-point between k-means, that minimizes within-group
distances, and SVM, that tries to maximize between-group distances. Another important
consideration was that the method at all, could be applied to small datasets.
In this approache, the largest distances among members from the same group
and the smallest ones among members from different groups are the most important
values to be optimized. However, when groups have overlapping members, taking these
measures into account demands the optimization of the parameter “n”.  As the mean
distance  embraces  all  individuals,  it  would  optimize  general  group  cohesion  and
dispersion and make the method simpler in the latter  case.  The “F” and “n” factors
allow  researchers  to  adapt  the  objective  function  to  different  data  sets  by  giving
different weights to each component of the objective function and/or by changing the
number of extreme values to be optimized.
As  a  multivariate  filter,  it  just  selects  features  according  to  the  predefined
function.  In  order  to  have  a  diagnostic  tool,  it  is  necessary  to  couple  it  with  a
discriminant method, like hierarchical clustering, nearest-neighbour, decision trees or
SVMs (Larrañaga et al, 2006). Multidimensional scaling, although imprecise, gives a
very intuitive output.
Although our method showed interesting results, to have reasonable biosignature
candidates, reliable data from good experimental design are necessary and, as for any
prediction,  they  need  confirmation  before  can  be  considered  true  biosignatures
(Koulman et al, 2009). It is noteworthy that complete discrimination among different
groups is not always possible, as it also depends heavily on the data structure.
Every test was performed with microarray data for biochemical discrimination.
However, in our opinion, there is no reason to believe that the same method will not
work with different “omical” data and for different purposes. In fact, it would work with
any data set from any research field when the purpose is to find those variables that best
discriminate among different groups. 
Besides presenting a new method for putative biosignature identification, as far
we know, pyBioSig is the first free and open-source tool for the purpose that allows
simple and comfortable  analysis  via a graphical interface but also allows the use of
scripts for batch analyses. On the one hand, Python scripts offer flexibility and allow
researchers to test the effect of setting different parameters more efficiently. Also, as GA
is  a  stochastic  method,  it  is  convenient  to  try  different  runs  with  the  same  initial
parameters (Russell and Norvig, 2009). On the other hand, as our objective function
does not require understanding of complex linear algebra and the evolutionary process
is  intuitive  to  most  researchers  of  natural  sciences,  we believe  that  unlike  previous
works (Ooi and Tan, 2003; Peng et al, 2003; Liu et al, 2005), with the simple interface
provided,  we  are  also  providing  a  powerful  and  effective  tool  accessible  even  to
researchers with lower computer expertise.
CONCLUSIONS
Our results allow us to conclude that using GA to minimize the largest and mean
distances  among members  from the same group while  maximizing the smallest  and
mean  distances  among  members  from different  groups  is  an  effective  and efficient
strategy  for  the  identification  of  putative  molecular  biosignatures  that  allow
discrimination among multiple groups. It is also clear and computationally feasible and,
in  theory,  can  be  used  to  seek  putative  biosignatures  for  any  number  of  groups
simultaneously, even from small datasets. 
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Figures
Figure 1.  Frequency of the different probes selected in 30 independent  searches for
putative biosignatures over an artificial data set. Blue bars represent the frequency of
selected  informative  probes,  whereas  red  ones  represent  the  frequency  of  selected
uninformative or noisy probes. 
Figure  2. Comparison  of  the  probes  in  the  biosignature  generated  using  pyBioSig
software and those from a nonspecific filter of the artificial data set. The figures on the
right  are  analyses  of  biosignature  data,  while  the  ones  on  the  left  are  from  the
nonspecific filter. A and B are the hierarchical clusterings using Euclidean distance and
clustering  by  the  mean  distance  (UPGMA);  the  green  values  above  each  cluster
represent bootstrap support, while the red ones are approximately unbiased p-values. C
and D are multidimensional scalings using Euclidean distance, with the color of points
representing samples from the same group as in A and B. E and F are heatmaps of the
resulting probes, with rows and columns ordered by hierarchical clustering.
Figure  3. Comparison  of  the  probes  in  the  biosignature  generated  using  pyBioSig
software and those from the nonspecific filter of the GSE5429 data set. The right-hand
figures  are  analyses  of  biosignature  data,  while  the  left-hand  ones  are  from  the
nonspecific filter. A and B are the hierarchical clusterings using Euclidean distance and
clustering  by  the  mean  distance  (UPGMA);  the  green  values  above  each  cluster
represent bootstrap support, while the red ones are approximately unbiased p-values. C
and D are multidimensional scalings using Euclidean distance, with the color of points
representing samples from the same group as in A and B. E and F are heatmaps of the
resulting probes, with rows and columns ordered by hierarchical clustering.
